Search results
Assess HER2 Status in Solid Tumors to Inform Eligibility for Enhertu
GenomeWeb News· 4 days agoThis core visual aid from AstraZeneca and Daiichi Sankyo describes the relevance and prevalence of HER2 positivity across metastatic solid tumors; provides detail on the nuances of ASCO-CAP ...